
The final 2020 monthly edition of Pharmafocus is available to read for free online now! After a long and theatrical …

Regeneron has slammed the brakes on its Phase 1 trial of garetosmab in the treatment of the ultra-rare condition fibrodysplasia …

Results from a newly published clinical trial suggest that a new compound could treat a broad range of schizophrenia symptoms. …

Matt Hancock, the UK’s Health Secretary, has said that more patients with the COVID-19 coronavirus are need in clinical trials …

The FDA’s Drugs Trials Snapshots 2019 report has been released, clarifying the demographic distribution of participants who were included in …

A federal judge in New York’s Southern District has ruled that 10 years of unpublished clinical trial data must now …

MIT researchers have identified a new antibiotic compound using a machine-learning algorithm. In the laboratory tests, the drug killed many …

The National Institute for Health and Care Excellence (NICE) has not recommended Keytruda (pembrolizumab) and Inlyta (axitinib) for the treatment …

Patients regularly find value in participating in clinical trials, but many are not given the option by medical professionals and …
Clinical trials are one of the longest and most expensive steps of bringing a drug to market. Conor Kavanagh investigates …

Clinical trials are the backbone of healthcare and drug research, but many key patient populations have in the past been …

Health professionals in the Democratic Republic of Congo (DRC) are now offering two experimental drugs to people infected with Ebola, …

Biotech firm Transgene has announced its decision to terminate a study investigating the efficacy of its oncolytic immunotherapy product Pexa-Vec …

Pfizer has said its sickle cell drug rivipansel failed to meet its primary endpoint or key secondary endpoints in a …

Acadia Pharmaceuticals has said its schizophrenia drug Nuplazid (primavanserin) has failed to beat placebo in a Phase 3 trial. Nuplazid …